CBLN1 and osteoarthritis: For instance, Liu Q. et al discovered that circRNA-CER decreased expression in osteoarthritis (OA) and regulated MMP13 expression as a competing endogenous RNA (ceRNA) and involving in the processof chondrocyte ECM degradation, suggesting that circRNA-CER could be used as a potential target in OA therapy [43].